glycemic control in acutely ill patients
DESCRIPTION
Glycemic Control in Acutely Ill Patients. Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for Medical Affairs, Joslin Diabetes Center. Questions to Ask. - PowerPoint PPT PresentationTRANSCRIPT
Glycemic Control in Acutely Ill Patients
Martin J. Abrahamson, MD FACPAssociate Professor of Medicine, Harvard Medical
SchoolSenior Vice President for Medical Affairs, Joslin
Diabetes Center
Questions to Ask
• Is hyperglycemia associated with increased morbidity/mortality in acutely ill patients?
• Will lowering glucose improve outcomes for acutely ill patients?
• What glucose levels should be attained in the acutely ill patient?
• How do we best do this?
Mortality Increases with Increases in Average ICU BG
Krinsley JS: Mayo Clin Proc. 2003;78:1471-1478.
(1826 consecutive ICU patients 10/99 thru 4/02)
Intensive Insulin Therapy and Mortality in Patients Admitted to SICU
• 1548 consecutive admissions to SICU
• Randomly assigned (with stratification based on type of critical illness) to conventional vs intensive insulin treatment
Van de Berghe G, et al. NEJM 2001;345:1359-1367
• Conventional treatment– Standardized nutritional therapy and intravenous
insulin therapy if BG >215 mg/dl to maintain blood glucose <200 mg/dl.
• Intensive therapy– Standardized nutritional therapy and intravenous
insulin therapy if BG>110 mg/dl to maintain glucose 80 - 110 mg/dl.
Intensive Insulin Therapy and Mortality in Patients Admitted to SICU
Intensive Insulin Therapy in Critically Ill Surgical Patients
Conventional Treatment
Intensive Treatment
Trigger for starting iv insulin
> 215 > 100
Glucose achieved
153 + 33 103 + 19
% with glucose < 40 mg/dL
0.7 5
Glucose in mg/dL Van den Berghe et al. NEJM 2001; 345:1359-1367
Intensive Insulin Therapy in Surgical ICU Patients Reduces Mortality
Conventional: insulin when blood glucose > 215 mg/dLmean BG = 153 mg/dL
Intensive: insulin when glucose > 110 mg/dL and maintained at 80-110 mg/dL
mean BG = 103 mg/dL
Survival in ICU (%)
100
96
92
88
800
84
0 20 40 60 80 100 120 140 160
Intensive treatment
Conventional treatment
Days after Admission
4.6% mortality
8% mortality
Van den Berghe, G. NEJM. 2001;345:1359–1367.
Intensive Insulin Therapy in Surgical ICU Patients Reduces Morbidity and Mortality
Percent Reduction
Mortality Sepsis Dialysis Polyneuropathy
Blood Transfusio
n
34%
46%41% 44%
50%
Van den Berghe, G. NEJM. 2001;345:1359–1367.
What about Intensive Therapy in the MICU?
♦ 1,200 patients who “were considered to need intensive care for at least 3 days”
♦ Randomized to two groups:♦ IV insulin to achieve glucose 80-110 mg/dl♦ Conventional therapy using insulin for blood
glucose > 215 mg/dl and tapered when < 180 mg/dl
♦ 16.9% of these patients had diabetes
NEJM 354:449, 2006
Intensive Insulin Therapy in Critically Ill Medical Patients
Conventional Treatment
Intensive Treatment
Trigger for starting iv insulin
> 215 > 100
Glucose achieved
153 111
% with glucose < 40 mg/dL
3.1 18.7
Glucose in mg/dL Van den Berghe et al. NEJM 2006; 354:449-460
Intensive Insulin in the MICU Does Not Decrease Mortality
• In-hospital deaths– Conventional
Therapy: 40%– Intensive Insulin
Therapy: 37.3%
NEJM 354:449, 2006
P = 0.33
100
80
60
40
20
A. Intention-to-Treat Group (n = 1,200)
Intensive treatment
Conventional treatment
00 100 200 300 400 500
Days
First 30 days
100
80
60
40
00 10 20 30
In-H
ospi
tal S
urvi
val (
%)
Subgroup in ICU ≥ 3 days (n = 767)
P = 0.009
NEJM 354:449, 2006
100
80
60
40
20
B. Subgroup in ICU ≥3 Days (n = 767)
Intensive treatment
Conventional treatment
00 50 150200250 350
Days
First 30 days
100
80
60
40
00 10 20 30
In-H
ospi
tal S
urvi
val (
%)
100 300 500
• In-hospital deaths– Conventional
Therapy: 52.5%– Intensive Insulin
Therapy: 43.0%
Effect of Intensive Insulin Therapy on Morbidity
NEJM 354:449, 2006
4.0
3.0
2.0
1.0
0.00 10203040506070 8
090
Intensivetreatment
Conventionaltreatment
P=0.03
Weaning from MechanicalVentilation
Cum
ulat
ive
Haz
ard
3.5
2.5
1.5
0.5
5.0
4.0
0.00 010200300400 50
0600
P=0.05
Discharge from Hospital
3.02.01.0
4.5
3.5
2.5
1.00.0
0 20 40 60 80
100
P=0.04
Discharge from ICU
4.0
3.0
2.0
0.5
1.5
A
Days After Admission to ICU
> 3 days in ICU (n = 767)
3.5
2.5
1.5
0.50.0
Intensivetreatment
Conventionaltreatment
P<0.001
Weaning from MechanicalVentilation
B
Cum
ulat
ive
Haz
ard
0 10203040506070 80
90
1.0
2.0
3.05.0
1.00.0
0 100200300400 500
600
Discharge from Hospital
4.03.0
2.0
4.0
3.0
2.0
1.0
0.00 20 40 60 8
0100
P=0.04
Discharge from ICU
3.5
2.5
0.5
1.5
P=0.01
Days After Admission to ICU
Conclusions• Intensive insulin therapy significantly
reduced morbidity but not mortality among all patients in the MICU.
• Although the risk of subsequent death and disease was reduced in patients treated for ≥3 days, these patients could not be identified before therapy.
NEJM 354:449, 2006
Diabetes Care in the Hospital: NICE-SUGAR Study (1)
• Largest randomized controlled trial to date• Tested effect of tight glycemic control
(target 81–108 mg/dL) on outcomes among 6,104 critically ill participants
• Majority (>95%) required mechanical ventilation
ADA. IX. Diabetes Care in Specific Settings. Diabetes Care. 2013;36(suppl 1):S46.
Diabetes Care in the Hospital: NICE-SUGAR Study (2)
• In both surgical/medical patients, 90-day mortality significantly higher in intensively treated vs conventional group (target 144–180 mg/dL)– Severe hypoglycemia more common
(6.8% vs 0.5%; P<0.001)– Findings strongly suggest may not be
necessary to target blood glucose levels<140 mg/dL; highly stringent target of<110 mg/dL may be dangerous
ADA. IX. Diabetes Care in Specific Settings. Diabetes Care. 2013;36(suppl 1):S46.
So what glycemic target should be attempted for acutely ill patients admitted with diabetes?
ADA Recommendations• Critically ill patients:
• 140 – 180 mg/dL • Start iv insulin when glucose exceeds 180
mg/dL• Goal of 110 – 140 mg/dL may be appropriate
for some patients if there is no risk of hypoglycemia
• Non-critically ill• Premeal < 140 mg/dL mg/dL• Random <180 mg/dL
So how do we manage someonewho requires insulin
and is NPO or too ill to eat?
Using Sliding Scale SC Insulin is Like Being on a Roller Coaster!
IT IS A RELIC FROM THE PASTAND SHOULD BE AVOIDED
WHEREVER AND WHENEVER POSSIBLE!!
Estimating Insulin Dose for Infusion
• Infusion of 1.0 - 2.0 units/hr usually maintains blood glucose in 120 - 180mg/dL range
• Insulin requirements depend on – Previous therapy– Degree of control– Use of steroids– Presence of sepsis– Type of surgery
• Increased insulin requirements for renal transplant and open heart surgery
Guidelines for Insulin Infusion
• Decreased insulin needs– Patients requiring diet and/or oral agents– Patients taking less than 50 U of insulin per day
• Increased insulin needs– Obesity, hepatic disease (x 1.5)– Steroid therapy (x2)– Sepsis (x2)– Renal transplant (x 2)– Open heart surgery (x 3-5)
Insulin Infusion AlgorithmDecision to initiate iv insulin
•If BG < 200 mg/dL start with D5 ½ N Saline at 60 – 100 cc/hr• If BG > 300 mg/dL give iv regular insulin 0.1U/kg stat
Initiate at an hourly rate of total daily dose of insulin / 24For patients not usually on insulin start at 0.02 U/kg/hr
Check BG hourly
Adjustment of Insulin is dependent on current glucose,previous glucose
and rate of change of glucose
Transitioning to SC Insulin• Do not stop iv insulin before giving some
short acting insulin sc• Usually continue iv infusion by about 1
hour after administration of short acting sc insulin
• Plan to stop iv after a meal – preferably during the day
• Ensure that there is always intermediate or long acting insulin given to cover basal requirements
Remember – Insulin Requirements..
• Basal
• Prandial/Nutritional
• Correction or Supplemental
Summary
• Hyperglycemia is associated with increased morbidity and mortality in acutely ill patients
• Maintaining glucose levels between 140 and 180 mg/dL in acutely ill patients is associated with the least morbidity and optimal outcomes
• Using iv insulin infusion to achieve this in the ICU is the preferred modality of administering insulin